Stockholders' Equity - 2026 Securities Purchase Agreement (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Jan. 13, 2026 |
Jan. 08, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Stockholders' Equity | ||||
| Transaction costs | $ 5,860 | $ 294 | ||
| 2026 Securities Purchase Agreement | ||||
| Stockholders' Equity | ||||
| Number of common stock shares issued | 1,408,481 | |||
| Price per share | $ 2.35 | |||
| Gross proceeds from sale of equity | $ 26,000 | |||
| Transaction costs | $ 1,700 | |||
| Warrant exercise, common stock ownership limitation | 4.99% | |||
| Warrant exercise, common stock ownership limitation (at the election of the holder) | 9.99% | |||
| Warrant holder's election, period of written notice | 61 days | |||
| 2026 Securities Purchase Agreement | 2026 Pre-Funded Warrants | ||||
| Stockholders' Equity | ||||
| Number of shares which may be issued upon conversion of warrants | 9,653,257 | |||
| Price per warrant | $ 2.349 | |||
| Warrants, exercise price | $ 0.001 | |||
| X | ||||||||||
- Definition The effective ownership of the outstanding shares of the Company's common stock immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed. No definition available.
|
| X | ||||||||||
- Definition The effective ownership of the outstanding shares of the Company's common stock, with written notice given by the holder to the Company, immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each warrant issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Minimum days of prior written notice needed to satisfy the holder's election to exercise warrants that give the holder, together with affiliates, a beneficial ownership in the Company's common stock of not more than 9.99%. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|